Hyperbaric Medicine, or Hyperbaric Oxygen Therapy (HBOT)
Hyperbaric medicine, or hyperbaric oxygen therapy (HBOT), is the medical use of oxygen at a level higher than atmospheric pressure. Atmospheric pressure is defined as the pressure exerted by the weight of air in the atmosphere of Earth.  It is measured with a barometer.  Hyperbaric chambers were initially developed as a treatment for the bends, or decompression
Mitochondria Appear Good Treatment Target for Stroke and TBI Recovery
Summary: Researchers believe that, given time, mitochondria can recover their normal form following TBI or stroke. Source: Medical College of Georgia at Augusta University. Cell powerhouses are typically long and lean, but with brain injury such as stroke or trauma, they can quickly become bloated and dysfunctional, say scientists who documented the phenomena in real time
New blood test for prion disease looks promising
Written by Catharine Paddock PhD Scientists have developed an accurate biochemical test that detects prions in the blood of patients with variant Creutzfeldt-Jakob disease. If validated, it could lead to a valuable tool for pre-symptom diagnosis of the disease and screening of donated blood supply. The team – led by senior author Claudio Soto, professor
Stroke & Pregnancy
A new study reports younger higher risk of stroke than older pregnant women and non-pregnant women of the same age. Younger pregnant women, including the postpartum period up to six weeks after delivery, appeared to be at increased risk of stroke compared with their nonpregnant counterparts, and that increased stroke risk was not associated with older pregnant women,
Does Cannabis Help Seizures?
Evidence from laboratory studies, anecdotal reports, and small clinical studies from a number of years ago suggests that cannabidiol, a non-psychoactive compound of cannabis, could potentially be helpful in controlling seizures. However, there are conflicting reports in the literature. So far, scientifically controlled studies have not shown definitive proof of the effectiveness and safety of
A Phase I Study of AM0010 in Patients with Advanced Solid Tumors A Phase 1, Open-Label Dose Escalation First-in-Human Study to Evaluate the Tolerability, Safety, Maximum Tolerated Dose, Preliminary Clinical Activity, and Pharmacokinetics of AM0010 in Patients with Advanced Solid Tumors Purpose The purpose of this study is to find the highest dose of the
Perspective New Treatments in the Horizon for Traumatic Brain Injuries
Milos Cekic; Donald G. Stein Future Neurology. 2010;5(1):3746. Abstract and Background Abstract Traumatic brain injury is a significant clinical problem for which there is still no effective treatment. Recent laboratory and clinical data demonstrate a potentially beneficial role for neurosteroids, such as progesterone and allopregnanolone, in the treatment of traumatic brain injury, ischemic stroke and some neurodegenerative
Allergen Purchases Tobira Therapeutics
Allergan Plc’s agreement to buy Tobira Therapeutics Inc. for as much as $1.7 billion sent biotech stocks soaring Tuesday, as investors bet that buyers will emerge for other companies developing experimental treatments for a liver disease known as NASH. NASH, or non-alcoholic steatohepatitis, is a severe type of fatty liver disease that has become one of the hottest areas in biotech
MRI Scans May Be Useful in Diagnosing Chronic Traumatic Encephalopathy
Originally posted on neurosciencenews.com Summary: Researchers report MRI brain scans may be an early and easier way to diagnose CTE. Source: UCLA. UCLA doctors have found what may be an earlier and easier way to diagnose chronic traumatic encephalopathy, or CTE, a disorder that is thought to affect some former football players and others with
AbbVie to Expand Oncology Presence
AbbVie: To Expand Oncology Presence Through Acquisition of Stemcentrx and its Novel, Late-Stage Rova-T Compound for Small Cell Lung Cancer NORTH CHICAGO, Ill., April 28, 2016 /PRNewswire/ — AbbVie (NYSE:ABBV), a global biopharmaceutical company, announced that it will acquire Stemcentrx and its lead late-stage asset rovalpituzumab tesirine (Rova-T) currently in registrational trials for small cell
Page 3 of 512345



iPT Tweets




New York, USA
Telephone : 718-332-7878
rkrishna -AT- ipharmatrials.com
.. replace -AT- with @

United Kingdom
The Studio/East Batterlaw Farm
Seaham SR7 8RP

Corporation Registration Address:
330 Thornton Road Englewood NJ 07631